Issue Archive
July 2008 | Volume 7 | Issue 7
Editorials
The Role of Natural Products in Clinical Practice
This supplement to the Journal of Drugs in Dermatology was supported by a medical education grant from Johnson & Johnson....
Read More
Original Articles
Phototherapy in the Treatment of Acne Vulgaris
Background: Achieving an effective management of acne vulgaris with minimal complications remains a difficult challenge for physicians. Moreover, the rise in antibiotic-resistant strains reduce the f...
Read MorePhotorejuvenation Using Topical 5-Methyl Aminolevulinate and Red Light
Background: Photodynamic therapy has been proved to be effective in skin rejuvenation.
Objective: To evaluate clinical efficacy and side effects of photodynamic therapy using topical 5-methyl...
Read MoreEfficacy of a Novel Combination of Pneumatic Energy and Broadband Light for the Treatment of Acne
Introduction: A novel photopneumatic platform (Isolaz, Pleasanton, CA), combining vacuum pressure with a broadband light source device has been designed to attack multiple targets for the effective t...
Read MoreTopical Tacrolimus 0.1% Improves Symptoms of Hand Dermatitis in Patients Treated With a Prednisone Taper
Background: Hand dermatitis is a chronic inflammatory skin disorder for which systemic immunosuppressive therapy is often needed. Topical treatments could complement the use of systemic corticosteroi...
Read MoreTrichoscopy: A New Method for Diagnosing Hair Loss
Abstract Videodermoscopy of hair and scalp (trichoscopy) is gaining popularity as a valuable tool in differential diagnosis of hair loss. This method allows viewing of the hair and scalp at X20 to X...
Read MoreSkin Directed Therapy for Mycosis Fungoides: A Review
Abstract Mycosis fungoides (MF) is a rare neoplasm of epidermotropic CD4+ lymphocytes and represents a majority of all cutaneous T cell lymphomas. Early stage MF is limited to cutaneous patches and ...
Read MoreDiclofenac Sodium 3% Gel in the Treatment of Actinic Keratoses Postcryosurgery
Background: Actinic keratoses are increasingly common skin lesions that are evaluated and treated by dermatologists on a daily basis. It is estimated that more than 90% of actinic keratoses in the US...
Read More
Features
SCHOOLS OF PHARMACOLOGY
Seborrheic dermatitis is a common papulosquamous disorder of the skin, affecting 3% to 5% of the population. Dandruff, a less severe form of seborrheic dermatitis, affects a greater proportion of the...
Read MoreNEWS, VIEWS, REVIEWS
PIPELINE PREVIEWS
Case Reports
Polyurethane Dressing Assisted Epidermal Suturing Minimizes Postoperative Wound Care
An exact vertical approximation of epidermal edges during wound suturing allows rapid reepithelialization of the sutured wound and may reduce scar formation. Over 20 patients have been treated with a...
Read MoreClinical Management With Efalizumab of a Patient with Psoriasis and Comorbid Vitiligo
Although the precise pathogenesis is not known, vitiligo appears to be an autoimmune disease involving T cell-mediated melanocyte destruction. Efalizumab, a recombinant, humanized monoclonal antibody...
Read MoreNew-onset Psoriasis and Psoriatic Arthritis in a Patient Treated with Bacillus Calmette-Guerin (BCG)Immunotherapy
Chemowraps as an Adjuvant to Surgery for Patients With Diffuse Squamous Cell Carcinoma of the Extremities
Background: Managing patients with diffuse squamous cell carcinoma (SCC) and actinic damage on their extremities is challenging because SCCs may be ill-defined, confluent, and only amenable to radica...
Read MoreXanthotrichia (Yellow Hair) Due to Selenium Sulfide and Dihydroxyacetone
Hair shaft discoloration has been documented to be caused by disease states, medications, and exogenous chemicals. After researching the literature, xanthotrichia or yellow hair has been determined t...
Read MoreSertraline-associated Hair Loss
Introduction: Many commonly prescribed prescription drugs such as dopaminergic therapies can cause temporary hair loss. Sertraline is a selective serotonin reuptake inhibitor. Its relative potency fo...
Read MorePsoralen Plus Ultraviolet A-induced Bullous Pemphigoid
